A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Библиографические подробности
Главный автор:	Islam, Saidul
Другие авторы:	Sharmin, Shahana
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2022
Предметы:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Online-ссылка:	http://hdl.handle.net/10361/17308

Схожие документы

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
по: Karim, Azrin
Опубликовано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
по: Meem, Manila
Опубликовано: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
по: Alam, Tahera
Опубликовано: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
по: Jahan, Nusrat
Опубликовано: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
по: Ahmed, Nafisa
Опубликовано: (2023)

Immunotherapy in the Management of Lung Cancer
по: Tasnim, Humayra
Опубликовано: (2022)

A review on triple-negative breast cancer and its potential treatment
по: Niasa, Jannatul Ferdous
Опубликовано: (2023)

Stem cells as therapeutic carrier in cancer treatment
по: Anika, Mysha Yeasmin
Опубликовано: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
по: Hasan, Amit
Опубликовано: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
по: Chakraborty, Anuradha
Опубликовано: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
по: Khan, Muidul Hasan
Опубликовано: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
по: Roy, Hredita
Опубликовано: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
по: Emon, Kamrul Hasan
Опубликовано: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
по: Mirza, Maisa Tasnim
Опубликовано: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
по: Khan, Rezia Nowrin
Опубликовано: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
по: Nuha, Nabiha Tahsin
Опубликовано: (2024)

Role of statins as antagonists of SPARC in gastric cancer
по: Shahmat, Rad
Опубликовано: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
по: Sorno, Rubina Haque
Опубликовано: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
по: Ratu, Tabassum
Опубликовано: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
по: Choki, Kinley
Опубликовано: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
по: Razna, Amrin Islam
Опубликовано: (2019)

A comprehensive review on drug repurposing in cancer treatment
по: Sarkar, Onusree
Опубликовано: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
по: Mahaleka, Aarshi
Опубликовано: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
по: Shaikat, Mahdi Mubin
Опубликовано: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
по: Hasan, Sakib
Опубликовано: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
по: Nawar, Anika
Опубликовано: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
по: Deeba, Maliha Tasnim
Опубликовано: (2018)

Targeting BRAFV600E in the treatment of CRC
по: Roja, Mashwiyat Samrin
Опубликовано: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
по: Alam, Kazi Tasnuva
Опубликовано: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
по: Rahman, Sanjida
Опубликовано: (2024)

Biosimilar in lymphoma treatment
по: Tanisha, Mehrin Haque
Опубликовано: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
по: Khondokar, Faiza
Опубликовано: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
по: Islam, Nahidul
Опубликовано: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
по: Beruni, Sajid Mahmud Al
Опубликовано: (2022)

Oncogenes: new targets in cancer treatment
по: Chowdhury, Waseka Shams
Опубликовано: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
по: Muntaha, Habibatul
Опубликовано: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
по: Haque, Mushfiqul
Опубликовано: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Karim, Samia Binte
Опубликовано: (2024)